Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Shares Repurchased (2016 - 2017)

Iradimed (IRMD) has disclosed Shares Repurchased for 2 consecutive years, with -$1.0 as the latest value for Q4 2017.

  • Quarterly Shares Repurchased changed N/A to -$1.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $265348.0 through Dec 2017, down 97.34% year-over-year, with the annual reading at $1.8 million for FY2017, 81.76% down from the prior year.
  • Shares Repurchased for Q4 2017 was -$1.0 at Iradimed, down from $265349.0 in the prior quarter.
  • The five-year high for Shares Repurchased was $5.5 million in Q1 2016, with the low at -$1.0 in Q4 2017.